Supplementary Data — Ensovibep for COVID-19: real-time meta analysis of 2 studies

@CovidAnalysis, December 2025, Version 9V9
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ EMPATHY Kingsley (DB RCT) 89% 0.11 [0.01-2.27] death 0/301 2/99 Improvement, RR [CI] Treatment Control EMPATHY Kingsley (DB RCT) 78% 0.22 [0.06-0.76] hosp./ER 4/301 6/99 EMPATHY Kingsley (DB RCT) 87% 0.13 [0.03-0.67] hosp. 2/301 5/99 EMPATHY Kingsley (DB RCT) 87% 0.13 [0.03-0.67] misc. 2/301 5/99 EMPATHY Kingsley (DB RCT) 30% 0.70 [0.44-1.11] no recov. 100 (n) 99 (n) EMPATHY Kingsley (DB RCT) 39% 0.61 [0.39-0.95] no recov. 100 (n) 99 (n) EMPATHY Kingsley (DB RCT) 39% 0.61 [0.39-0.95] no recov. 101 (n) 99 (n) EMPATHY Kingsley (DB RCT) -1% 1.01 [0.82-1.24] PASC 146/243 50/84 ACTIV-3/TICO Barkauskas (DB RCT) 28% 0.72 [0.46-1.14] death 33/247 43/238 ACTIV-3/TICO Barkauskas (DB RCT) 17% 0.83 [0.51-1.35] death 30/247 35/238 ACTIV-3/TICO Barkauskas (DB RCT) 11% 0.89 [0.65-1.20] death/hosp. 80/247 85/238 ACTIV-3/TICO Barkauskas (DB RCT) 6% 0.94 [0.78-1.14] no recov. 44/247 48/238 ACTIV-3/TICO Barkauskas (DB RCT) -8% 1.08 [0.77-1.49] no recov. 247 (n) 238 (n) ACTIV-3/TICO Barkauskas (DB RCT) 7% 0.93 [0.78-1.11] no disch. 28/247 34/238 Ensovibep COVID-19 outcomes c19early.org December 2025 Favors ensovibep Favors control
Fig. S1. All outcomes.